GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cerus Corporation (CERS) [hlAlert]

Rating:
Outperform
CERS
up 27.06 %

Cerus Corporation (CERS) upgraded to Outperform with price target $6 by Robert W. Baird

Posted on: Wednesday,  Feb 29, 2012  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Cerus Corporation (NASDAQ: CERS) on 02/29/2012, when the stock price was $3.88. Since
then, Cerus Corporation has gained 27.06% as of 01/07/2016's recent price of $4.93.
If you would have followed this Robert W. Baird's recommendation on CERS, you would have gained 27.06% of your investment in 1408 days.

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/29/2012 8:25 AM Buy
None
3.88 6.00
as of 12/31/2012
1 Week down  -2.76 %
1 Month down  -2.16 %
3 Months down  -7.05 %
1 YTD down  -18.55 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/4/2011 8:25 AM Hold
None
2.88 3.00
3/9/2010 8:25 AM Buy
None
2.57 5.00
7/28/2009 8:25 AM Hold
None
2.42 3.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy